DCOY Decoy Therapeutics Inc.
Nasdaq · SEC CIK 1615219 · EDGAR
- Bought, last 12 months
- $19.8K 2 purchases by 2 insiders
- Sold, last 12 months
- $17.28 2 sales by 1 insiders
- Filings on record
- 62 since 2021-08-11, latest 2026-09-02 18:32
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Rosenblum Mark J | CFO, EVP Fin | $16.0K | — |
| HANISH ARNOLD C | Dir | $3,750 | $17.28 |
| Gauthier Patricia G. | Dir | — | — |
| Marschel Peter Klaus | Chief Business Off | — | — |
| Hibner Barbara Louise | CSO | — | — |
| Burleson Tess | Dir | — | — |
| McVicar William K. | Dir | — | — |
| Lammers Paul | Dir | — | — |
| Lieber Jonathan I | Dir | — | — |
| PIERCE FREDERICK II | CEO | — | — |
Transactions 48
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 18:32 | 2026-08-31 | DCOY | Lieber Jonathan I | Dir | A - Grant | $0.00 | +2,000 | 2,002 | +100,000% | $0 | |
| 2026-09-02 17:50 | 2026-08-31 | DCOY | PIERCE FREDERICK II | CEO | A - Grant | $0.00 | +33.5K | 34.8K | +2,409% | $0 | |
| 2026-09-02 17:49 | 2026-08-31 | DCOY | Marschel Peter Klaus | Chief Business Off | A - Grant | $0.00 | +3,900 | 3,900 | New | $0 | |
| 2026-09-02 17:48 | 2026-08-31 | DCOY | Rosenblum Mark J | CFO | A - Grant | $0.00 | +9,682 | 11.4K | +576% | $0 | |
| 2026-09-02 17:46 | 2026-08-31 | DCOY | Hibner Barbara Louise | CSO | A - Grant | $0.00 | +4,216 | 4,216 | New | $0 | |
| 2026-09-02 17:45 | 2026-08-31 | DCOY | HANISH ARNOLD C | Dir | A - Grant | $0.00 | +3,000 | 3,418 | +718% | $0 | |
| 2026-09-02 17:42 | 2026-08-31 | DCOY | Lammers Paul | Dir | A - Grant | $0.00 | +2,000 | 2,001 | +200,000% | $0 | |
| 2026-09-02 17:41 | 2026-08-31 | DCOY | Burleson Tess | Dir | A - Grant | $0.00 | +2,000 | 2,002 | +100,000% | $0 | |
| 2026-09-02 17:40 | 2026-08-31 | DCOY | McVicar William K. | Dir | A - Grant | $0.00 | +3,000 | 3,002 | +150,000% | $0 | |
| 2026-09-02 17:39 | 2026-08-31 | DCOY | Gauthier Patricia G. | Dir | A - Grant | $0.00 | +2,000 | 2,000 | New | $0 | |
| I | 2026-01-02 | 2025-12-30 | DCOY | HANISH ARNOLD C | Dir | S - Sale | $0.64 | -15 | 5,000 | -0.3% | -$9.60 |
| 2026-01-02 | 2025-12-30 | DCOY | HANISH ARNOLD C | Dir | S - Sale | $0.64 | -12 | 0 | -100% | -$7.68 | |
| I | 2025-11-24 | 2025-11-20 | DCOY | HANISH ARNOLD C | Dir | P - Purchase | $0.75 | +5,000 | 5,015 | +33,333% | +$3,750 |
| 2025-11-20 | 2025-11-20 | DCOY | Rosenblum Mark J | CFO, EVP Fin | P - Purchase | $0.8 | +20.0K | 20.2K | +11,299% | +$16.0K | |
| 2023-02-15 | 2023-02-13 | DCOY | Arthur David J. | CEO, Dir | A - Grant | $0.00 | +14.3K | 48.0K | +42% | $0 | |
| 2023-02-15 | 2023-02-13 | DCOY | Rosenblum Mark J | CFO, EVP Fin | A - Grant | $0.00 | +6,432 | 21.9K | +42% | $0 | |
| 2023-01-05 | 2023-01-03 | DCOY | HANISH ARNOLD C | Dir | A - Grant | $0.00 | +1,440 | 1,440 | New | $0 | |
| 2023-01-05 | 2023-01-03 | DCOY | McCreedy Bruce J Jr. | Dir | A - Grant | $0.00 | +1,440 | 1,788 | +414% | $0 | |
| 2023-01-05 | 2023-01-03 | DCOY | Rosenblum Mark J | CFO, EVP Fin | A - Grant | $0.00 | +8,000 | 15.4K | +108% | $0 | |
| 2023-01-05 | 2023-01-03 | DCOY | Burleson Tess | Dir | A - Grant | $0.00 | +1,440 | 2,722 | +112% | $0 | |
| 2023-01-05 | 2023-01-03 | DCOY | Lammers Paul | Dir | A - Grant | $0.00 | +1,440 | 1,718 | +518% | $0 | |
| 2023-01-05 | 2023-01-03 | DCOY | Arthur David J. | CEO, Dir | A - Grant | $0.00 | +20.0K | 33.7K | +146% | $0 | |
| 2023-01-05 | 2023-01-03 | DCOY | Lieber Jonathan I | Dir | A - Grant | $0.00 | +1,440 | 2,940 | +96% | $0 | |
| 2023-01-05 | 2023-01-03 | DCOY | McVicar William K. | Dir | A - Grant | $0.00 | +1,440 | 1,788 | +414% | $0 | |
| A | 2022-12-12 | 2022-11-03 | DCOY | Arthur David J. | CEO, Dir | A - Grant | $1.73 | +2,693 | 13.7K | +24% | +$4,659 |
| A | 2022-12-12 | 2022-11-03 | DCOY | Rosenblum Mark J | CFO, EVP Fin | A - Grant | $1.73 | +1,488 | 7,419 | +25% | +$2,574 |
| A | 2022-11-08 | 2022-11-03 | DCOY | Arthur David J. | CEO, Dir | A - Grant | $1.73 | +10.0K | 21.0K | +91% | +$17.3K |
| A | 2022-11-08 | 2022-11-03 | DCOY | Rosenblum Mark J | CFO, EVP Fin | A - Grant | $1.73 | +7,314 | 13.2K | +123% | +$12.7K |
| 2022-11-07 | 2022-11-03 | DCOY | Rosenblum Mark J | CFO, EVP Fin | A - Grant | $1.73 | +7,314 | 155.6K | +5% | +$12.7K | |
| 2022-11-07 | 2022-11-03 | DCOY | Arthur David J. | CEO, Dir | A - Grant | $1.73 | +10.0K | 285.7K | +4% | +$17.3K | |
| 2022-06-08 | 2022-06-07 | DCOY | Burleson Tess | Dir | P - Purchase | $0.18 | +27.7K | 32.0K | +637% | +$4,986 | |
| 2022-06-08 | 2022-06-07 | DCOY | Lieber Jonathan I | Dir | P - Purchase | $0.19 | +37.5K | 37.5K | New | +$7,125 | |
| I | 2022-06-07 | 2022-06-06 | DCOY | McVicar William K. | Dir | P - Purchase | $0.19 | +26.6K | 26.6K | New | +$5,045 |
| AI | 2022-06-06 | 2019-11-25 | DCOY | HANISH ARNOLD C | Dir | P - Purchase | $3.59 | +3,000 | 3,000 | New | +$10.8K |
| AI | 2022-06-06 | 2020-02-11 | DCOY | HANISH ARNOLD C | Dir | P - Purchase | $1.15 | +4,350 | 7,350 | +145% | +$5,002 |
| AI | 2022-06-06 | 2020-08-21 | DCOY | HANISH ARNOLD C | Dir | P - Purchase | $0.98 | +4,000 | 11.3K | +54% | +$3,920 |
| I | 2022-06-06 | 2022-06-03 | DCOY | HANISH ARNOLD C | Dir | P - Purchase | $0.18 | +28.0K | 46.4K | +153% | +$5,040 |
| MI | 2022-05-31 | 2022-05-26 | DCOY | Arthur David J. | CEO, Dir | P - Purchase | $0.18 | +21.9K | 282.4K | +8% | +$3,942 |
| M | 2022-05-31 | 2022-05-26 | DCOY | Arthur David J. | CEO, Dir | P - Purchase | $0.18 | +22.0K | 281.7K | +8% | +$3,960 |
| 2022-05-31 | 2022-05-31 | DCOY | Rosenblum Mark J | CFO, EVP Fin | P - Purchase | $0.18 | +28.0K | 148.3K | +23% | +$5,040 | |
| 2022-05-05 | 2022-05-03 | DCOY | Arthur David J. | CEO, Dir | A - Grant | $0.19 | +10.0K | 259.7K | +4% | +$1,900 | |
| 2022-05-05 | 2022-05-03 | DCOY | Rosenblum Mark J | CFO, EVP Fin | A - Grant | $0.19 | +10.0K | 120.3K | +9% | +$1,900 | |
| 2022-03-09 | 2022-03-03 | DCOY | Rosenblum Mark J | CFO, EVP Fin | P - Purchase | $0.39 | +76.2K | 110.3K | +224% | +$29.7K | |
| 2022-03-09 | 2022-03-03 | DCOY | Arthur David J. | CEO, Dir | P - Purchase | $0.39 | +139.5K | 249.7K | +127% | +$54.4K | |
| 2021-11-05 | 2021-11-03 | DCOY | Arthur David J. | CEO, Dir | A - Grant | $0.72 | +7,939 | 110.2K | +8% | +$5,716 | |
| 2021-11-05 | 2021-11-03 | DCOY | Rosenblum Mark J | CFO, EVP Fin | A - Grant | $0.72 | +7,787 | 34.1K | +30% | +$5,607 | |
| MI | 2021-08-17 | 2021-08-17 | DCOY | Arthur David J. | CEO, Dir | P - Purchase | $0.895 | +4,000 | 102.2K | +4% | +$3,580 |
| I | 2021-08-11 | 2021-08-10 | DCOY | HANISH ARNOLD C | Dir | P - Purchase | $0.88 | +7,000 | 18.4K | +62% | +$6,160 |
Purchase Sale Sale after option exercise All abbreviations